safety and efficacy of mirabegron add on treatment to solifenacin in incontinent OAB subjects with an inadequate respose to intial 4 week solifenacin monotherapy

drake m., athanasiou s., herholdt c., kaper m., saleem t., huang m., ...More

Annual Meeting of the International-Continence-Society, 6 - 08 October 2015

  • Publication Type: Conference Paper / Full Text
  • Dokuz Eylül University Affiliated: Yes